TherapeuticsMD | TXMD - Loan Capital

Stock Price
2.09
Daily Change
-0.02 -0.95%
Monthly
-3.69%
Yearly
111.11%
Q2 Forecast
2.01

TherapeuticsMD reported $0 in Loan Capital for its fiscal quarter ending in March of 2022.





Loan Capital Change Date
AbbVie USD 62.97B 12M Sep/2025
Alterity Therapeutics Limited AUD 43.68K 59.53K Dec/2025
Cipla INR 2.98B 454.6M Sep/2025
Clal Biotechnology ILS 25.96M 18.48M Dec/2023
Compugen USD 0 0 Dec/2024
CSL USD 10.42B 273M Dec/2025
Grifols EUR 9.95B 722.93M Dec/2025
Novo Nordisk DKK 14.02B 224.49M Sep/2025
Pfizer USD 57.41B 93M Sep/2025
TherapeuticsMD USD 0 0 Mar/2022